29.53
前日終値:
$29.90
開ける:
$30.21
24時間の取引高:
912.11K
Relative Volume:
0.65
時価総額:
$2.07B
収益:
$2.76B
当期純損益:
$-358.70M
株価収益率:
-5.9416
EPS:
-4.97
ネットキャッシュフロー:
$-35.90M
1週間 パフォーマンス:
-3.72%
1か月 パフォーマンス:
+13.84%
6か月 パフォーマンス:
-22.70%
1年 パフォーマンス:
-30.65%
Quidelortho Corporation Stock (QDEL) Company Profile
名前
Quidelortho Corporation
セクター
電話
(858) 552-1100
住所
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
QDEL を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
QDEL
Quidelortho Corporation
|
29.53 | 2.07B | 2.76B | -358.70M | -35.90M | -4.97 |
![]()
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-05-08 | アップグレード | Jefferies | Hold → Buy |
2024-12-11 | アップグレード | Citigroup | Neutral → Buy |
2024-12-10 | 開始されました | Jefferies | Hold |
2024-09-19 | 再開されました | UBS | Neutral |
2024-09-05 | アップグレード | Craig Hallum | Hold → Buy |
2024-03-04 | ダウングレード | UBS | Neutral → Sell |
2024-02-14 | ダウングレード | JP Morgan | Neutral → Underweight |
2023-12-11 | ダウングレード | Citigroup | Buy → Neutral |
2022-12-12 | アップグレード | Citigroup | Neutral → Buy |
2022-12-07 | 開始されました | RBC Capital Mkts | Outperform |
2022-10-14 | アップグレード | UBS | Sell → Neutral |
2022-09-19 | 開始されました | Citigroup | Neutral |
2022-07-20 | 開始されました | UBS | Sell |
2022-06-17 | 再開されました | JP Morgan | Neutral |
2022-02-22 | アップグレード | Raymond James | Outperform → Strong Buy |
2021-01-22 | アップグレード | Raymond James | Mkt Perform → Outperform |
2020-05-12 | ダウングレード | JP Morgan | Neutral → Underweight |
2020-03-26 | ダウングレード | Barclays | Overweight → Equal Weight |
2018-10-23 | 再開されました | Raymond James | Strong Buy |
2018-03-08 | アップグレード | Raymond James | Outperform → Strong Buy |
2018-01-22 | 繰り返されました | Barclays | Overweight |
2018-01-04 | アップグレード | CL King | Neutral → Buy |
2017-09-19 | アップグレード | Piper Jaffray | Neutral → Overweight |
2017-07-18 | アップグレード | Canaccord Genuity | Hold → Buy |
2017-07-18 | アップグレード | William Blair | Mkt Perform → Outperform |
2017-04-25 | 繰り返されました | Canaccord Genuity | Hold |
2017-02-17 | 開始されました | CL King | Neutral |
2016-12-16 | ダウングレード | Piper Jaffray | Overweight → Neutral |
2016-06-13 | アップグレード | Raymond James | Mkt Perform → Outperform |
2016-02-18 | 繰り返されました | Barclays | Overweight |
2016-02-09 | ダウングレード | Canaccord Genuity | Buy → Hold |
2016-01-08 | 繰り返されました | Canaccord Genuity | Buy |
2015-12-14 | ダウングレード | Raymond James | Outperform → Mkt Perform |
2015-09-02 | 開始されました | Barclays | Overweight |
2013-07-31 | 繰り返されました | Canaccord Genuity | Buy |
2011-03-03 | ダウングレード | Wedbush | Outperform → Neutral |
すべてを表示
Quidelortho Corporation (QDEL) 最新ニュース
QuidelOrtho (QDEL) Down 18% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Clinical Laboratory Molecular Diagnostics for Infectious Disease Market Research 2025-2029: Biotechnology and Genomics Drive Advancements, Impact of Multiplex Assays in Diagnosis and Treatment - GlobeNewswire Inc.
Transcript : QuidelOrtho Corporation Presents at Jefferies Global Healthcare Conference 2025, Jun-05-2025 08 - marketscreener.com
QuidelOrtho Declares that its Molecular Diagnostics Approach will be Refocused - MSN
Transcript : QuidelOrtho Corporation Presents at 45th Annual William Blair Growth Stock Conference, Jun-04-2025 08 - marketscreener.com
QuidelOrtho Corp (QDEL) Stock Price Down 2.92% on Jun 2 - GuruFocus
QuidelOrtho to discontinue Savanna platform development - MSN
QuidelOrtho (QDEL) to Acquire LEX Diagnostics Amid Strategic Shi - GuruFocus
QuidelOrtho shifts focus with LEX Diagnostics deal, drops Savanna By Investing.com - Investing.com South Africa
Transcript : QuidelOrtho CorporationSpecial Call - marketscreener.com
QuidelOrtho (QDEL) to Acquire LEX Diagnostics Amid Strategic Shift - GuruFocus
QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics | QDEL Stock News - GuruFocus
QuidelOrtho (QDEL) Shifts Strategy, Plans to Acquire LEX Diagnos - GuruFocus
QuidelOrtho to discontinue Savanna platform development (QDEL:NASDAQ) - Seeking Alpha
QuidelOrtho announces a refocusing of its molecular diagnostics strategy - TipRanks
QuidelOrtho (QDEL) to acquire full ownership of LEX Diagnostics, announces strategy to accelerate growt - StreetInsider
QuidelOrtho Makes Major Molecular Diagnostics Pivot: $100M LEX Acquisition to Replace Savanna Platform - Stock Titan
Why QuidelOrtho (QDEL) is a Top Momentum Stock for the Long-Term - sharewise
Here's Why QuidelOrtho (QDEL) is a Strong Growth Stock - Yahoo Finance
QuidelOrtho Corp (QDEL) Stock Price Down 3.63% on May 29 - GuruFocus
QuidelOrtho Stockholders Approve Equity Plan Changes - TipRanks
Luxfer, LGI Homes, QuidelOrtho, Dentsply Sirona, and AdaptHealth Stocks Trade Up, What You Need To Know - Yahoo Finance
10,269 Shares in QuidelOrtho Co. (NASDAQ:QDEL) Acquired by BNP Paribas Financial Markets - Defense World
QuidelOrtho’s SWOT analysis: diagnostics firm’s stock faces pivotal year - Investing.com
Asian Hospital, Faridabad Becomes the First in the City to Launch Total Lab Automation with QuidelOrtho - APN News
QuidelOrtho to Participate in Upcoming June 2025 Investor Conferences - BioSpace
QuidelOrtho to Participate in Upcoming Investor Conferences | QDEL Stock News - GuruFocus
Asian Hospital, Faridabad introduces total lab automation with QuidelOrtho - IndiaMedToday
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now - MSN
QuidelOrtho Management to Present at William Blair and Jefferies Healthcare Conferences Next Month - Stock Titan
Asian Hospital in Faridabad launches total lab automation in partnership with QuidelOrtho - BioSpectrum India
QuidelOrtho Corp (QDEL) Stock Price Down 3.32% on May 19 - GuruFocus
Captrust Financial Advisors Boosts Holdings in QuidelOrtho Co. (NASDAQ:QDEL) - Defense World
Ameriprise Financial Inc. Has $10.84 Million Holdings in QuidelOrtho Co. (NASDAQ:QDEL) - Defense World
Why QuidelOrtho (QDEL) is a Top Growth Stock for the Long-Term - Yahoo Finance
QuidelOrtho Corporation (NASDAQ:QDEL) Surges 32% Yet Its Low P/S Is No Reason For Excitement - simplywall.st
Northern Trust Corp Raises Stock Holdings in QuidelOrtho Co. (NASDAQ:QDEL) - Defense World
QuidelOrtho (QDEL) Faces Tariff Impact, Maintains 2025 Outlook - GuruFocus
Why QuidelOrtho Corporation (QDEL) Went Up On Thursday - MSN
Thermo Fisher, Biogen, Gilead Sciences, Moderna, and QuidelOrtho Stocks Trade Up, What You Need To Know - MSN
QuidelOrtho: Stagnant Growth Means Best To Avoid (Rating Downgrade) (NASDAQ:QDEL) - Seeking Alpha
Quidelortho sees $30M-$40M tariff impact offset, maintains 2025 guidance - MSN
QuidelOrtho Stock Gains Following Q1 Earnings Beat, Margins Expand - MSN
QuidelOrtho First Quarter 2025 Earnings: EPS Beats Expectations - simplywall.st
Jefferies upgrades QuidelOrtho to Buy, says ‘no news is good news’ - TipRanks
10 Unexpected Market Movers – What Propelled Double-Digit Gains? - Insider Monkey
QuidelOrtho Earnings Call: Growth Amid Challenges - TipRanks
Quidelortho Corporation (QDEL) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):